MAP3K5 and plasma cell myeloma: However, inhibition of IGF-1R by SSTNIGF1R prevents these inhibitory phosphorylation events, allowing ASK-1 autoactivation, its subsequent activation of JNK/SAPK, and entry of myeloma cells into apoptosis (40) (Figure 1B).